annual cash & cash equivalents:
$414.00M-$451.00M(-52.14%)Summary
- As of today (May 31, 2025), BSX annual cash & cash equivalents is $414.00 million, with the most recent change of -$451.00 million (-52.14%) on December 31, 2024.
- During the last 3 years, BSX annual cash & cash equivalents has fallen by -$1.51 billion (-78.49%).
- BSX annual cash & cash equivalents is now -78.49% below its all-time high of $1.93 billion, reached on December 31, 2021.
Performance
BSX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$725.00M+$311.00M(+75.12%)Summary
- As of today (May 31, 2025), BSX quarterly cash & cash equivalents is $725.00 million, with the most recent change of +$311.00 million (+75.12%) on March 31, 2025.
- Over the past year, BSX quarterly cash & cash equivalents has dropped by -$1.60 billion (-68.87%).
- BSX quarterly cash & cash equivalents is now -75.11% below its all-time high of $2.91 billion, reached on June 30, 2024.
Performance
BSX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BSX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.1% | -68.9% |
| 3 y3 years | -78.5% | +123.1% |
| 5 y5 years | +90.8% | +96.0% |
BSX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | at low | -75.1% | +162.7% |
| 5 y | 5-year | -78.5% | +90.8% | -75.1% | +162.7% |
| alltime | all time | -78.5% | +6916.9% | -75.1% | >+9999.0% |
BSX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $725.00M(+75.1%) |
| Dec 2024 | $414.00M(-52.1%) | $414.00M(-83.5%) |
| Sep 2024 | - | $2.50B(-14.1%) |
| Jun 2024 | - | $2.91B(+25.1%) |
| Mar 2024 | - | $2.33B(+169.2%) |
| Dec 2023 | $865.00M(-6.8%) | $865.00M(-9.1%) |
| Sep 2023 | - | $952.00M(+123.5%) |
| Jun 2023 | - | $426.00M(-25.3%) |
| Mar 2023 | - | $570.00M(-38.6%) |
| Dec 2022 | $928.00M(-51.8%) | $928.00M(+174.6%) |
| Sep 2022 | - | $338.00M(+22.5%) |
| Jun 2022 | - | $276.00M(-15.1%) |
| Mar 2022 | - | $325.00M(-83.1%) |
| Dec 2021 | $1.93B(+11.0%) | $1.93B(-1.1%) |
| Sep 2021 | - | $1.95B(-27.2%) |
| Jun 2021 | - | $2.67B(+32.7%) |
| Mar 2021 | - | $2.02B(+16.3%) |
| Dec 2020 | $1.73B(+699.1%) | $1.73B(-14.2%) |
| Sep 2020 | - | $2.02B(+17.3%) |
| Jun 2020 | - | $1.72B(+365.9%) |
| Mar 2020 | - | $370.00M(+70.5%) |
| Dec 2019 | $217.00M(+48.6%) | $217.00M(-21.7%) |
| Sep 2019 | - | $277.00M(+125.2%) |
| Jun 2019 | - | $123.00M(-11.5%) |
| Mar 2019 | - | $139.00M(-4.8%) |
| Dec 2018 | $146.00M(-22.3%) | $146.00M(-13.1%) |
| Sep 2018 | - | $168.00M(-19.2%) |
| Jun 2018 | - | $208.00M(-27.5%) |
| Mar 2018 | - | $287.00M(+52.7%) |
| Dec 2017 | $188.00M(-4.1%) | $188.00M(-10.5%) |
| Sep 2017 | - | $210.00M(+7.7%) |
| Jun 2017 | - | $195.00M(+25.0%) |
| Mar 2017 | - | $156.00M(-20.4%) |
| Dec 2016 | $196.00M(-38.6%) | $196.00M(-17.3%) |
| Sep 2016 | - | $237.00M(-45.9%) |
| Jun 2016 | - | $438.00M(+29.6%) |
| Mar 2016 | - | $338.00M(+6.0%) |
| Dec 2015 | $319.00M(-45.7%) | $319.00M(-8.9%) |
| Sep 2015 | - | $350.00M(-61.2%) |
| Jun 2015 | - | $903.00M(+273.1%) |
| Mar 2015 | - | $242.00M(-58.8%) |
| Dec 2014 | $587.00M(+170.5%) | $587.00M(+138.6%) |
| Sep 2014 | - | $246.00M(-31.1%) |
| Jun 2014 | - | $357.00M(+86.9%) |
| Mar 2014 | - | $191.00M(-12.0%) |
| Dec 2013 | $217.00M(+4.8%) | $217.00M(-62.0%) |
| Sep 2013 | - | $571.00M(+7.7%) |
| Jun 2013 | - | $530.00M(+97.8%) |
| Mar 2013 | - | $268.00M(+29.5%) |
| Dec 2012 | $207.00M(-22.5%) | $207.00M(-41.2%) |
| Sep 2012 | - | $352.00M(-5.1%) |
| Jun 2012 | - | $371.00M(+30.6%) |
| Mar 2012 | - | $284.00M(+6.4%) |
| Dec 2011 | $267.00M(+25.4%) | $267.00M(-3.3%) |
| Sep 2011 | - | $276.00M(+79.2%) |
| Jun 2011 | - | $154.00M(-74.1%) |
| Mar 2011 | - | $595.00M(+179.3%) |
| Dec 2010 | $213.00M(-75.3%) | $213.00M(-73.7%) |
| Jun 2010 | - | $811.00M(+56.3%) |
| Mar 2010 | - | $519.00M(-39.9%) |
| Dec 2009 | $864.00M(-47.3%) | $864.00M(-37.4%) |
| Sep 2009 | - | $1.38B(+15.7%) |
| Jun 2009 | - | $1.19B(+33.1%) |
| Mar 2009 | - | $897.00M(-45.3%) |
| Dec 2008 | $1.64B | $1.64B(-5.4%) |
| Sep 2008 | - | $1.73B(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $1.62B(-7.1%) |
| Mar 2008 | - | $1.74B(+19.8%) |
| Dec 2007 | $1.45B(-12.9%) | $1.45B(+17.4%) |
| Sep 2007 | - | $1.24B(-18.3%) |
| Jun 2007 | - | $1.51B(+13.0%) |
| Mar 2007 | - | $1.34B(-19.7%) |
| Dec 2006 | $1.67B(+142.1%) | $1.67B(+8.2%) |
| Sep 2006 | - | $1.54B(+33.2%) |
| Jun 2006 | - | $1.16B(+6.8%) |
| Mar 2006 | - | $1.08B(+57.2%) |
| Dec 2005 | $689.00M(-46.8%) | $689.00M(-7.5%) |
| Sep 2005 | - | $745.00M(+6.7%) |
| Jun 2005 | - | $698.00M(-15.6%) |
| Mar 2005 | - | $827.00M(-36.2%) |
| Dec 2004 | $1.30B(+93.1%) | $1.30B(-16.0%) |
| Sep 2004 | - | $1.54B(+22.1%) |
| Jun 2004 | - | $1.26B(+105.4%) |
| Mar 2004 | - | $615.00M(-8.3%) |
| Dec 2003 | $671.00M(+142.2%) | $671.00M(+25.0%) |
| Sep 2003 | - | $537.00M(+31.0%) |
| Jun 2003 | - | $410.00M(+39.5%) |
| Mar 2003 | - | $294.00M(+6.1%) |
| Dec 2002 | $277.00M(+53.9%) | $277.00M(+6.9%) |
| Sep 2002 | - | $259.00M(+79.9%) |
| Jun 2002 | - | $144.00M(-28.4%) |
| Mar 2002 | - | $201.00M(+11.7%) |
| Dec 2001 | $180.00M(+233.3%) | $180.00M(+81.8%) |
| Sep 2001 | - | $99.00M(+80.0%) |
| Jun 2001 | - | $55.00M(-34.5%) |
| Mar 2001 | - | $84.00M(+55.6%) |
| Dec 2000 | $54.00M(-15.6%) | $54.00M(+20.0%) |
| Sep 2000 | - | $45.00M(+2.3%) |
| Jun 2000 | - | $44.00M(-21.4%) |
| Mar 2000 | - | $56.00M(-12.5%) |
| Dec 1999 | $64.00M(-8.6%) | $64.00M(-11.1%) |
| Sep 1999 | - | $72.00M(+4.3%) |
| Jun 1999 | - | $69.00M(-37.3%) |
| Mar 1999 | - | $110.00M(+57.1%) |
| Dec 1998 | $70.00M(+20.7%) | $70.00M(-64.1%) |
| Sep 1998 | - | $194.90M(+31.2%) |
| Jun 1998 | - | $148.60M(+4.2%) |
| Mar 1998 | - | $142.60M(+145.9%) |
| Dec 1997 | $58.00M(-19.7%) | $58.00M(+6.8%) |
| Sep 1997 | - | $54.30M(+0.4%) |
| Jun 1997 | - | $54.10M(-24.4%) |
| Mar 1997 | - | $71.60M(-0.8%) |
| Dec 1996 | $72.20M(-37.3%) | $72.20M(+21.5%) |
| Sep 1996 | - | $59.40M(+12.7%) |
| Jun 1996 | - | $52.70M(-49.4%) |
| Mar 1996 | - | $104.10M(-9.6%) |
| Dec 1995 | $115.10M(+27.9%) | $115.10M(-25.7%) |
| Sep 1995 | - | $155.00M(-14.1%) |
| Jun 1995 | - | $180.50M(-5.6%) |
| Mar 1995 | - | $191.20M(+112.4%) |
| Dec 1994 | $90.00M(+48.0%) | $90.00M(-5.6%) |
| Sep 1994 | - | $95.30M(+38.3%) |
| Jun 1994 | - | $68.90M(-2.4%) |
| Mar 1994 | - | $70.60M(+16.1%) |
| Dec 1993 | $60.80M(-36.3%) | $60.80M(+24.8%) |
| Sep 1993 | - | $48.70M(-5.6%) |
| Jun 1993 | - | $51.60M(-50.2%) |
| Mar 1993 | - | $103.60M(+8.6%) |
| Dec 1992 | $95.40M(+1516.9%) | $95.40M(-26.5%) |
| Sep 1992 | - | $129.80M(+10.2%) |
| Jun 1992 | - | $117.80M(+1254.0%) |
| Mar 1992 | - | $8.70M(+47.5%) |
| Dec 1991 | $5.90M | $5.90M |
FAQ
- What is Boston Scientific annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Boston Scientific?
- What is Boston Scientific annual cash & cash equivalents year-on-year change?
- What is Boston Scientific quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Boston Scientific?
- What is Boston Scientific quarterly cash & cash equivalents year-on-year change?
What is Boston Scientific annual cash & cash equivalents?
The current annual cash & cash equivalents of BSX is $414.00M
What is the all time high annual cash & cash equivalents for Boston Scientific?
Boston Scientific all-time high annual cash & cash equivalents is $1.93B
What is Boston Scientific annual cash & cash equivalents year-on-year change?
Over the past year, BSX annual cash & cash equivalents has changed by -$451.00M (-52.14%)
What is Boston Scientific quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BSX is $725.00M
What is the all time high quarterly cash & cash equivalents for Boston Scientific?
Boston Scientific all-time high quarterly cash & cash equivalents is $2.91B
What is Boston Scientific quarterly cash & cash equivalents year-on-year change?
Over the past year, BSX quarterly cash & cash equivalents has changed by -$1.60B (-68.87%)